Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aethlon Medical, Inc. - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AEMD
Nasdaq
3845
https://www.aethlonmedical.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aethlon Medical, Inc.
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
- Feb 21st, 2024 1:01 pm
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript
- Feb 15th, 2024 3:03 pm
AEMD: Focus on Oncology Studies; In Vitro Binding Study Expected to Advance Clinical Trial Activities
- Feb 15th, 2024 12:44 pm
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
- Feb 14th, 2024 9:15 pm
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
- Feb 7th, 2024 1:00 pm
AEMD: Expect Focus on Oncology Studies; Cost Containment Efforts
- Nov 16th, 2023 4:06 pm
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcript
- Nov 16th, 2023 2:35 pm
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
- Nov 14th, 2023 9:15 pm
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer
- Nov 13th, 2023 1:01 pm
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
- Nov 6th, 2023 1:01 pm
AEMD: Authorization to Conduct Study in India Moves Oncology Initiatives Ahead
- Oct 12th, 2023 2:19 pm
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology
- Oct 10th, 2023 12:01 pm
Aethlon Announces Reverse Stock Split
- Oct 4th, 2023 12:01 pm
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Aug 30th, 2023 12:01 pm
AEMD: Focusing on Oncology, Infectious Disease & Organ Transplants Initially
- Aug 14th, 2023 12:03 pm
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update
- Aug 10th, 2023 8:15 pm
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023
- Aug 3rd, 2023 12:01 pm
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant
- Jul 24th, 2023 12:01 pm
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
- Jul 6th, 2023 6:17 pm
AEMD: Expanding Research Efforts & Strengthening Team, While Minimizing R&D Spending
- Jul 6th, 2023 4:10 pm
Scroll